Intravenous nicorandil for treatment of the urgent phase acute heart failure syndromes: A randomized, controlled trial

European Heart Journal: Acute Cardiovascular Care

Volumn 6, Issue 4, 2017, Pages 329-338

  Harada, Kenji ^a   Yamamoto, Takashi ^a   Okumura, Takanobu ^a   Shigekiyo, Masahito ^a   Terada, Naho ^a   Okada, Ayumi ^a   Kawata, Atsushi ^a   Iima, Tsutomu ^a   Harada, Takafumi ^a   Fujisawa, Kazutoshi ^a   Kageyama, Norihito ^a   Saito, Akihiro ^a   Yamamoto, Hirofumi ^a   Fujinaga, Hiroyuki ^a  

^a TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Acute heart failure syndromes; dyspnea; echocardiography; nicorandil

Indexed keywords

DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; NICORANDIL; VASODILATOR AGENT;

ACUTE HEART FAILURE; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HEMODYNAMICS; HUMAN; HYPOTENSION; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; DEVICES; DIASTOLE; DRUG EFFECTS; ECHOCARDIOGRAPHY; EPIDEMIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITAL EMERGENCY SERVICE; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; DIASTOLE; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; INFUSIONS, INTRAVENOUS; JAPAN; MALE; MIDDLE AGED; NICORANDIL; NITROGLYCERIN; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 85061424734     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872616633837     Document Type: Article

References (31)

1. Gheorghiade M, Zannad F, Sopko G. Acute heart failure syndromes: Current state and framework for future research. Circulation 2005; 112: 3958–3968.
2. De Luca L, Mebazaa A, Filippatos G. Overview of emerging pharmacologic agents for acute heart failure syndromes. Eur J Heart Fail 2008; 10: 201–213.
3. Ramírez A, Abelmann WH. Cardiac decompensation. N Engl J Med 1974; 290: 499–501.
4. McMurray JJ, Adamopoulos S, Anker SD. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787–1847.
5. Yancy CW, Jessup M, Bozkurt B. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128: e240–e327.
6. JCS (Japanese Circulation Society) Joint Working Groups for Guidelines for Diagnosis and Treatment of Cardiovascular Diseases. Guidelines for Treatment of Acute Heart Failure (JCS 2006). http://www.j-circ.or.jp/guideline/pdf/JCS2006_maruyama_h.pdf (in Japanese).
7. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989; 63: 18J–24J.
8. Tanaka K, Kato K, Takano T. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure. J Cardiol 2010; 56: 291–299.
9. Minami Y, Nagashima M, Kajimoto K. Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: Usefulness of noninvasive echocardiographic hemodynamic evaluation. J Cardiovasc Pharmacol 2009; 54: 335–340.
10. Mckee PA, Castelli WP, McNamara PM. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441–1446.
11. Lang RM, Bierig M, Devereux RB. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440–1463.
12. Nagueh SF, Middleton KJ, Kopelen HA. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527–1533.
13. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 2002; 287: 1531–1540.
14. Metra M, Cleland JG, Weatherley BD. Dyspnoea in patients with acute heart failure: An analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study. Eur J Heart Fail 2010; 12: 499–507.
15. Metra M, O’Connor CM, Davison BA. Early dyspnoea relief in acute heart failure: Prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. Eur Heart J 2011; 32: 1519–1534.
16. Sato N, Kajimoto K, Asai K, Mizuno M. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: Rationale, design, and preliminary data. Am Heart J 2010; 159: 949–955.
17. Teerlink JR, Metra M, Felker GM. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): A multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 2009; 373: 1429–1439.
18. Massie BM, O’Connor CM, Metra M. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010; 363: 1419–1428.
19. O’Connor CM, Starling RC, Hernandez AF. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32–43.
20. Kato K, Takano T, Katagiri T. Clinical evaluation of intravenous nicorandil (sigmart) in patients with acute heart failure–the multi-center, randomized double blind placebo-controlled phase III study [in Japanese]. Jpn Pharmacol Ther 2008; 36: S65–S78.
21. Izawa H, Iwase M, Takeichi Y. Effect of nicorandil on left ventricular end-diastolic pressure during exercise in patients with hypertrophic cardiomyopathy. Eur Heart J 2003; 24: 1340–1348.
22. Cotter G, Metzkor E, Kaluski E. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389–393.
23. Shah SJ, Blair JE, Filippatos GS. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: Results from the hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: A randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am Heart J 2009; 157: 1035–1041.
24. Nazerian P, Vanni S, Zanobetti M. Diagnostic accuracy of emergency Doppler echocardiography for identification of acute left ventricular heart failure in patients with acute dyspnea: Comparison with Boston criteria and N-terminal prohormone brain natriuretic peptide. Acad Emerg Med 2010; 17: 18–26.
25. Mentz RJ, Hernandez AF, Stebbins A. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: Findings from ASCEND-HF. Eur J Heart Fail 2013; 15: 456–464.
26. Huang CH, Tsai MS, Hsieh CC. Diagnostic accuracy of tissue Doppler echocardiography for patients with acute heart failure. Heart 2006; 92: 1790–1794.
27. Sato N, Kajimoto K, Keida T. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND registry). Circ J 2013; 77: 944–951.
28. Kangawa K, Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 1984; 118: 131–139.
29. Nomura F, Kurobe N, Mori Y. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide effects observed through monitoring dyspnea in acute decompensated heart failure study. Circ J 2008; 72: 1777–1786.
30. Rivas-Gotz C, Manolios M, Thohan V. Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol 2003; 91: 780–784.
31. Kusunose K, Yamada H, Nishio S. Clinical utility of single-beat E/e’ obtained by simultaneous recording of flow and tissue Doppler velocities in atrial fibrillation with preserved systolic function. JACC Cardiovasc Imaging 2009; 2: 1147–1156.